Its why at Real Peptides, we focus on small-batch synthesis to ensure the amino acid sequence is exact every single time
However, the role of Rab4A-mediated endosome traffic beyond mTOR activation, T-cell lineage development and autoimmunity remain unknown
Persistent side effects beyond 2 weeks after a dose increase Transient nausea, mild constipation, and decreased appetite are expected and normal during the 1 to 2 weeks after each dose increase
They are support, not enhancement
The table below shows dosing for all three formulations: Egrifta SV (the current main product), Egrifta WR (a newer once-weekly-reconstitution version), and legacy Egrifta (the original 2 mg/day product used in trials)
The concentration is higher than intended